Ashley Sullivan
banner
aesully98.bsky.social
Ashley Sullivan
@aesully98.bsky.social
🦬 // PhD candidate in the Aaron Whiteley Lab at CU Boulder. she/her
Congrats as well to @erinedoherty.bsky.social and @benadler.bsky.social et al. in the @doudna-lab.bsky.social lab for their excellent complementary work on Panoptes! www.nature.com/articles/s41...
A miniature CRISPR–Cas10 enzyme confers immunity by inhibitory signalling - Nature
Panoptes, an anti-phage defence system against virus-mediated immune suppression, is revealed.
www.nature.com
October 3, 2025 at 4:11 PM
Huge shoutout and thanks to my lab mates in the @aaronwhiteley.bsky.social lab and our collaborators in the @benmorehouse.bsky.social lab. This work would not have been possible without you all! 🫶🏻
October 3, 2025 at 4:11 PM
Reposted by Ashley Sullivan
Thank you to everyone who helped make this story happen!

Obligatory meme to summarize:
“How I imagine phage facing CBASS and mCpol”
October 1, 2025 at 5:57 PM
Huge shout-out to all of the authors from the @aaronwhiteley.bsky.social and @benmorehouse.bsky.social labs that were so instrumental to this project! A special thank you to our collaborators L. Aravind and Max Burroughs for their incredible bioinformatic analyses!
March 31, 2025 at 10:00 PM
In total, we uncovered a novel mechanism of immune evasion sensing in bacteria. The Panoptes system is part of a “layered” immune system that flips the liability of a nucleotide-derived second messenger in immune signaling against the phage, adding an interesting dimension to phage-bacteria warfare.
March 31, 2025 at 10:00 PM
Finally, we wanted to explore the relationship between CBASS and Panoptes, given the importance of Acb2 in both nucleotide-based signaling systems. We found that 53% of all Panoptes systems co-occur with CBASS, suggesting that Panoptes systems are predominantly guardians of CBASS in bacteria.
March 31, 2025 at 10:00 PM
Consistent with this, we found that OptE robustly inhibited bacterial growth unless an OptS-derived nucleotide was present and that OptS constitutively synthesizes 2′,3′-c-di-AMP in vivo in the absence of phage infection.
March 31, 2025 at 10:00 PM
These data led us to hypothesize that OptS-synthesized nucleotides were actually inhibiting, rather than activating, the OptE effector. Upon phage infection, however, Acb2 sequesters the OptS product away from OptE, unleashing its growth inhibition effect.
March 31, 2025 at 10:00 PM
These findings left us puzzled: How does the Acb2 nucleotide sponge protein activate the Panoptes system? Based on its ability to bind diverse nucleotide products, we proposed that Acb2 also binds the product of OptS (2′,3′-c-di-AMP), which is exactly what we found.
March 31, 2025 at 10:00 PM
Acb2 was recently discovered by the Bondy-Denomy and Chen Labs to be an anti-defense protein that acts as a nucleotide “sponge,” sequestering CBASS-derived cyclic oligonucleotide signaling molecules.
March 31, 2025 at 10:00 PM
Intriguingly, the escaper phages we identified encoded loss-of-function mutations exclusively in the anti-CBASS 2 (acb2) gene. Consistent with this, we found that acb2 was necessary and sufficient to activate Panoptes defense.
March 31, 2025 at 10:00 PM
We now knew that nucleotide signaling was a key component of the Panoptes system, but we were left wondering: how does the phage activate defense? To answer this question, we turned to phages that were able to escape Panoptes.
March 31, 2025 at 10:00 PM
We tested the activity of OptS by incubating it with a range of NTPs and found that it used ATP as a substrate to specifically produce 2′,3′-c-di-AMP, an isomer of c-di-AMP. We used a series of phosphodiesterases to show that the linkage included a 3′–5′ and 2′–5′ bond.
March 31, 2025 at 10:00 PM